Elite Pharmaceuticals, Inc. Loans Payable
Elite Pharmaceuticals, Inc. (ELTP) had Loans Payable of $4.94 thousand as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Liabilities › Debt › Loans Payable
us-gaap:LoansPayable · last filed 2026-06-29
- 2025-09-30: Loans Payable $4.94K.
- 2025-06-30: Loans Payable $15.30K.
- 2025-03-31: Loans Payable $32.32K.
- 2024-12-31: Loans Payable $76.80K.
| Period end | Loans Payable |
|---|---|
| 2025-09-30 | $4.94K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $15.30K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $32.32K 10-K · filed 2026-06-29 |
| 2024-12-31 | $76.80K 10-Q · filed 2025-02-13 |
| 2024-09-30 | $160.67K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $243.80K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $128.46K 10-K · filed 2025-06-30 |
| 2023-03-31 | $259.61K 10-K · filed 2023-06-29 |
| 2022-12-31 | $14.82M 10-Q · filed 2023-02-14 |
| 2022-09-30 | $14.90M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $12.40M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $502.05K 10-K · filed 2023-06-29 |
| 2021-12-31 | $596.30K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $750.16K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $906.64K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $815.06K 10-K · filed 2022-06-29 |
| 2020-12-31 | $900.80K 10-Q · filed 2021-02-16 |
| 2020-09-30 | $931.20K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $1.06M 10-Q · filed 2020-08-14 |
| 2020-04-30 | $1.01M 10-Q · filed 2020-11-16 |
| 2020-03-31 | $1.03M 10-K · filed 2021-06-14 |
| 2019-12-31 | $886.82K 10-Q · filed 2020-02-10 |
| 2019-09-30 | $958.64K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.07M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $1.27M 10-K · filed 2020-06-29 |
| 2018-12-31 | $1.28M 10-Q · filed 2019-02-11 |
| 2018-03-31 | $1.20M 10-K · filed 2019-06-21 |